AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of June 30, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,112 inpatient beds, including 732 licensed detoxification beds, 26 standalone outpatient centers, and 5 sober living facilities across 409 beds for a total of 1,521 combined inpatient and sober living beds. It also offers Internet marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities; and online marketing solutions to other treatment providers, such as facility profiles, audience targeting, lead generation, and tools for digital reputation management. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:AAC
Previous Symbol
CUSIPN/A
Phone615-732-1231
Debt
Debt-to-Equity Ratio2.58
Current Ratio2.17
Quick Ratio2.17
Price-To-Earnings
Trailing P/E Ratio3.60
Forward P/E Ratio10.80
P/E GrowthN/A
Sales & Book Value
Annual Sales$317.64 million
Price / Sales0.17
Cash Flow$1.5429 per share
Price / Cash Flow1.40
Book Value$5.67 per share
Price / Book0.38
Profitability
EPS (Most Recent Fiscal Year)$0.60
Net Income$-20,570,000.00
Net Margins-10.20%
Return on Equity4.21%
Return on Assets1.15%
Miscellaneous
Employees2,100
Outstanding Shares24,600,000
Market Cap$53.14 million
OptionableOptionable
AAC (NYSE:AAC) Frequently Asked Questions
What is AAC's stock symbol?
AAC trades on the New York Stock Exchange (NYSE) under the ticker symbol "AAC."
How were AAC's earnings last quarter?
AAC Holdings Inc (NYSE:AAC) announced its quarterly earnings results on Tuesday, November, 6th. The company reported ($0.08) EPS for the quarter, missing the Zacks' consensus estimate of $0.24 by $0.32. The company earned $77.47 million during the quarter, compared to analysts' expectations of $84.21 million. AAC had a positive return on equity of 4.21% and a negative net margin of 10.20%. AAC's revenue for the quarter was down 3.7% on a year-over-year basis. During the same period last year, the firm earned $0.12 earnings per share. View AAC's Earnings History.
When is AAC's next earnings date?
What guidance has AAC issued on next quarter's earnings?
AAC issued an update on its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $-0.15--0.1 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.72. The company issued revenue guidance of $315-320 million, compared to the consensus revenue estimate of $337.24 million.AAC also updated its FY18 guidance to ($0.15-0.10) EPS.
What price target have analysts set for AAC?
2 brokers have issued twelve-month price targets for AAC's stock. Their predictions range from $4.00 to $12.00. On average, they expect AAC's share price to reach $8.00 in the next year. This suggests a possible upside of 270.4% from the stock's current price. View Analyst Price Targets for AAC.
What is the consensus analysts' recommendation for AAC?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AAC.
What are Wall Street analysts saying about AAC stock?
Here are some recent quotes from research analysts about AAC stock:
- 1. According to Zacks Investment Research, "AAC Holdings, Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. It provides detoxification, residential treatment, partial hospitalization, and intensive outpatient care services. AAC Holdings, Inc. is headquartered in Brentwood, Tennessee. " (10/17/2018)
- 2. Cantor Fitzgerald analysts commented, "1Q18 results were ahead of consensus on both the top and bottom lines, although consensus is comprised of only three estimates. Results were boosted by the AdCare acquisition (closed March 1), but we expect more earnings impact from AdCare in 2Q18 and beyond." (5/2/2018)
Has AAC been receiving favorable news coverage?
Press coverage about AAC stock has trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AAC earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are some of AAC's key competitors?
Some companies that are related to AAC include LogicBio Therapeutics (LOGC), ADMA Biologics (ADMA), ProMetic Life Sciences (PFSCF), Galectin Therapeutics (GALT), BioLife Solutions (BLFS), Strongbridge Biopharma (SBBP), Pulse Biosciences (PLSE), Allergy Therapeutics (AGYTF), LifeVantage (LFVN), CELYAD SA/ADR (CYAD), Newron Pharmaceuticals (NWPHF), Semler Scientific (SMLR), Synlogic (SYBX), Paratek Pharmaceuticals (PRTK) and Zafgen (ZFGN).
Who are AAC's key executives?
AAC's management team includes the folowing people:
- Mr. Michael T. Cartwright, Chairman & CEO (Age 50)
- Dr. Thomas W. Doub, Chief Compliance Officer & Chief Clinical Officer (Age 49)
- Mr. Michael Nanko Ph.D., Pres & COO (Age 62)
- Mr. Andrew W. McWilliams, CFO & Chief Accounting Officer (Age 46)
- Mr. Michael J. Stetar, Chief Technology Officer
Who are AAC's major shareholders?
AAC's stock is owned by a number of of retail and institutional investors. Top institutional investors include Morgan Stanley (6.08%), San Francisco Sentry Investment Group CA (5.55%), Royce & Associates LP (3.98%), BlackRock Inc. (3.23%), Vanguard Group Inc. (2.58%) and Vanguard Group Inc (2.58%). Company insiders that own AAC stock include Darrell S Freeman, David C Kloeppel, Jerrod N Menz, Michael J Blackburn, Michael Nanko, Michael T Cartwright and W Larry Cash. View Institutional Ownership Trends for AAC.
Which institutional investors are selling AAC stock?
AAC stock was sold by a variety of institutional investors in the last quarter, including San Francisco Sentry Investment Group CA, Blair William & Co. IL and Connor Clark & Lunn Investment Management Ltd.. Company insiders that have sold AAC company stock in the last year include David C Kloeppel, Michael J Blackburn and Michael T Cartwright. View Insider Buying and Selling for AAC.
Which institutional investors are buying AAC stock?
AAC stock was purchased by a variety of institutional investors in the last quarter, including Royce & Associates LP, Mondrian Investment Partners LTD, Morgan Stanley, GSA Capital Partners LLP, Bank of New York Mellon Corp, Woodmont Investment Counsel LLC, Vanguard Group Inc and Vanguard Group Inc.. Company insiders that have bought AAC stock in the last two years include Darrell S Freeman, Michael Nanko and W Larry Cash. View Insider Buying and Selling for AAC.
How do I buy shares of AAC?
Shares of AAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AAC's stock price today?
One share of AAC stock can currently be purchased for approximately $2.16.
How big of a company is AAC?
AAC has a market capitalization of $53.14 million and generates $317.64 million in revenue each year. The company earns $-20,570,000.00 in net income (profit) each year or $0.60 on an earnings per share basis. AAC employs 2,100 workers across the globe.
What is AAC's official website?
How can I contact AAC?
AAC's mailing address is 200 POWELL PLACE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-732-1231 or via email at [email protected]
MarketBeat Community Rating for AAC (NYSE AAC)
MarketBeat's community ratings are surveys of what our community members think about AAC and other stocks. Vote "Outperform" if you believe AAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
